Pharmacogenomics on the Treatment Response in Patients with Psoriasis: An Updated Review.

Author: ChangYa-Ching, ChenChun-Bing, ChenWei-Ti, ChungWen-Hung, HuiRosaline Chung-Yee, WangChing-Ya, WangChuang-Wei

Paper Details 
Original Abstract of the Article :
The efficacy and the safety of psoriasis medications have been proved in trials, but unideal responses and side effects are noted in clinical practice. Genetic predisposition is known to contribute to the pathogenesis of psoriasis. Hence, pharmacogenomics gives the hint of predictive treatment respo...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138383/

データ提供:米国国立医学図書館(NLM)

Pharmacogenomics: Unlocking the Secrets of Personalized Psoriasis Treatment

Psoriasis is a chronic skin condition that affects millions worldwide. While various medications are available to manage psoriasis, individual responses to treatment can vary significantly. This review examines the emerging field of pharmacogenomics, exploring how genetic factors can influence treatment outcomes in patients with psoriasis. The authors delve into the potential of pharmacogenomics to predict treatment response and optimize individual care.

A New Era of Personalized Medicine: Pharmacogenomics in Psoriasis

The review highlights the potential of pharmacogenomics to personalize psoriasis treatment, identifying genetic factors that influence drug efficacy and side effect profiles. [Pharmacogenomics's potential in psoriasis treatment]. These findings pave the way for a more individualized approach to psoriasis management, leading to improved treatment outcomes and patient satisfaction.

A Camel's Perspective on Personalized Medicine

Imagine a camel crossing a desert, its journey tailored to its unique abilities and needs. Personalized medicine is a similar approach to healthcare, recognizing that individuals respond differently to treatments. This review explores the potential of pharmacogenomics in psoriasis treatment, offering a personalized approach that considers each patient's genetic makeup. Just as a camel's journey is guided by its innate strengths, personalized medicine aims to tailor treatments to each individual's unique characteristics, maximizing their chances of a successful outcome.

Dr. Camel's Conclusion

This review underscores the promise of pharmacogenomics in revolutionizing psoriasis treatment. By understanding the genetic factors that influence drug response, healthcare providers can tailor treatments to each individual patient, leading to more effective and personalized care. Continued research in pharmacogenomics holds exciting possibilities for transforming the management of psoriasis and other chronic diseases.

Date :
  1. Date Completed 2023-05-01
  2. Date Revised 2023-05-01
Further Info :

Pubmed ID

37108492

DOI: Digital Object Identifier

PMC10138383

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.